Ofer Levy mostly deals with Immunology, Innate immune system, Immune system, Immunity and Surgery. Immunology is represented through his Toll-like receptor, Monocyte, Cytokine, TLR4 and Inflammation research. His Innate immune system research is multidisciplinary, incorporating perspectives in Acquired immune system, Neonatal sepsis, Sepsis, Microbiology and Bactericidal/permeability-increasing protein.
His research in Immune system intersects with topics in Agonist, Disease and Antigen. His Immunity research is multidisciplinary, relying on both Myeloid, Lipopolysaccharide, Ontogeny and Vaccination. His work on Shoulder joint, Prosthesis, Orthopedic surgery and Arthroplasty as part of general Surgery research is frequently linked to Arthropathy, thereby connecting diverse disciplines of science.
His primary areas of investigation include Immunology, Immune system, Surgery, Innate immune system and Immunity. Cytokine, Antibody, Immunization, Adjuvant and Inflammation are the primary areas of interest in his Immunology study. His study looks at the relationship between Cytokine and fields such as TLR4, as well as how they intersect with chemical problems.
The Immune system study which covers Vaccination that intersects with Public health. Ofer Levy studied Innate immune system and Microbiology that intersect with Bacteria. His work in Immunity is not limited to one particular discipline; it also encompasses Monocyte.
Immune system, Immunology, Immunization, Immunity and Vaccination are his primary areas of study. His Innate immune system and Acquired immune system study are his primary interests in Immune system. Ofer Levy combines subjects such as Progenitor cell, Heterologous and Tuberculosis with his study of Innate immune system.
His research on Immunology frequently links to adjacent areas such as Flagellin. His studies in Immunization integrate themes in fields like Adjuvant, HIV vaccine, Public health and Intensive care medicine. The concepts of his Immunity study are interwoven with issues in Young adult, Hepatitis B and Clinical trial.
His primary areas of study are Immunology, Immune system, Neonatal sepsis, Immunogenicity and Immunization. His Immunology research is multidisciplinary, incorporating elements of Granulopoiesis, Flagellin and CD40. His research in Immune system is mostly focused on Innate immune system.
Ofer Levy interconnects Tumor necrosis factor alpha, Myelopoiesis, Pathophysiology and Granulocyte in the investigation of issues within Neonatal sepsis. Ofer Levy has researched Immunogenicity in several fields, including Acquired immune system and Adjuvant. His Immunization research includes themes of Inflammation, Reprogramming, Metabolomics, Immunity and Metabolic pathway.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
Noa Stanietsky;Hrvoje Simic;Jurica Arapovic;Amir Toporik.
Proceedings of the National Academy of Sciences of the United States of America (2009)
Innate immunity of the newborn: basic mechanisms and clinical correlates
Nature Reviews Immunology (2007)
Selective Impairment of TLR-Mediated Innate Immunity in Human Newborns: Neonatal Blood Plasma Reduces Monocyte TNF-α Induction by Bacterial Lipopeptides, Lipopolysaccharide, and Imiquimod, but Preserves the Response to R-848
Ofer Levy;Ofer Levy;Ofer Levy;Kol A. Zarember;Rene M. Roy;Rene M. Roy;Colette Cywes;Colette Cywes.
Journal of Immunology (2004)
Innate Immune Function by Toll-like Receptors: Distinct Responses in Newborns and the Elderly
Tobias R. Kollmann;Ofer Levy;Ruth R. Montgomery;Stanislas Goriely.
Selective predisposition to bacterial infections in IRAK-4–deficient children: IRAK-4–dependent TLRs are otherwise redundant in protective immunity
Cheng Lung Ku;Horst Von Bernuth;Horst Von Bernuth;Capucine Picard;Shen Ying Zhang.
Journal of Experimental Medicine (2007)
Clinical Features and Outcome of Patients With IRAK-4 and MyD88 Deficiency
Capucine Picard;Capucine Picard;Horst Von Bernuth;Horst Von Bernuth;Horst Von Bernuth;Pegah Ghandil;Pegah Ghandil;Pegah Ghandil;Maya Chrabieh;Maya Chrabieh.
Cementless surface replacement arthroplasty of the shoulder. 5- to 10-year results with the Copeland mark-2 prosthesis.
O. Levy;S. A. Copeland.
Journal of Bone and Joint Surgery-british Volume (2001)
Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia
Geraldine Canny;Ofer Levy;Glenn T. Furuta;Sailaja Narravula-Alipati.
Proceedings of the National Academy of Sciences of the United States of America (2002)
Challenges in infant immunity: implications for responses to infection and vaccines
Mercy Prabhudas;Becky Adkins;Hayley Gans;Christopher King.
Nature Immunology (2011)
Therapeutic potential of the bactericidal/permeability-increasing protein.
Expert Opinion on Investigational Drugs (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: